Read this company snapshot
Daily valuation snapshot
Tempus AI, Inc. Class A Common Stock: source evidence dated 2026-10-09.
- Daily close (USD)
- $70.93
- Market capitalization (USD)
- $12,440,481,289.31
- Price / earnings (TTM)
- Not reported
- Price / book
- 27.96
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research TEM in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research TEM in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaboration agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology, as well as strategic collaboration with Personalis, Inc. and Whitehawk Therapeutics, Inc. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing TEM with another company.
| Daily close (USD) | $70.93 |
| Market capitalization (USD) | $12,440,481,289.31 |
| Price / earnings (TTM) | Not reported |
| Price / book | 27.96 |
No matching rows. Clear the filter to see all records.
Read TEM's valuation metrics
Company size
Tempus AI, Inc. Class A Common Stock's recorded market capitalization is $12,440,481,289.31. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
TEM's recorded price-to-book ratio is 27.96. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Tempus AI, Inc. Class A Common Stock with Aurora
Use the snapshot above to ask a specific question about TEM. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow TEM's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.